1
/
의
1
ELK Biotechnology
SKU(재고 관리 코드):ELK7875
General 17-OHP(17-Hydroxyprogesterone) ELISA Kit
General 17-OHP(17-Hydroxyprogesterone) ELISA Kit
General 17-OHP(17-Hydroxyprogesterone) ELISA Kit
Overview
| Product name: | 17-OHP(17-Hydroxyprogesterone) ELISA Kit |
| Reactivity: | General |
| Alternative Names: | 17OHP; 17-OH Progesterone; 17-Alpha-Hydroxyprogesterone |
| Assay Type: | Competitive Inhibition |
| Sensitivity: | 87.3 pg/mL |
| Standard: | 20000 pg/mL |
| Range: | 312.5-20000 pg/mL |
| Sample Type: | serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids |
| Assay Length: | 2h |
| Research Area: | Endocrinology;Reproductive science;Hormone metabolism; |
| Test principle: | This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with 17-OHP protein. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to 17-OHP. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of 17-OHP in the samples is then determined by comparing the OD of the samples to the standard curve. |
Standard curve
| Concentration (ng/mL) | OD | Corrected OD |
|---|---|---|
| 20000.00 | 0.215 | — |
| 10000.00 | 0.375 | — |
| 5000.00 | 0.527 | — |
| 2500.00 | 0.899 | — |
| 1250.00 | 1.157 | — |
| 625.00 | 1.537 | — |
| 312.50 | 1.887 | — |
| 0.00 | 2.232 | — |

Precision
Intra-assay Precision (Precision within an assay):CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays):CV%<10%
Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.
Recovery
Matrices listed below were spiked with certain level of recombinant 17-OHP and the recovery rates were calculated by comparing the measured value to the expected amount of 17-OHP in samples.
| Matrix | Recovery range | Average |
|---|---|---|
| serum(n=5) | 90-105% | 97% |
| EDTA plasma(n=5) | 86-99% | 92% |
| Heparin plasma(n=5) | 80-95% | 86% |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of 17-OHP and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Matrix | 1:2 | 1:4 | 1:8 | 1:16 |
|---|---|---|---|---|
| serum(n=5) | 78-92% | 83-96% | 91-103% | 96-105% |
| EDTA plasma(n=5) | 83-96% | 92-104% | 89-101% | 85-97% |
| Heparin plasma(n=5) | 85-94% | 91-103% | 85-97% | 87-96% |
Share
